409 related articles for article (PubMed ID: 18250362)
41. Telmisartan modulates mitochondrial function in vascular smooth muscle cells.
Takeuchi K; Yamamoto K; Ohishi M; Takeshita H; Hongyo K; Kawai T; Takeda M; Kamide K; Kurtz TW; Rakugi H
Hypertens Res; 2013 May; 36(5):433-9. PubMed ID: 23254392
[TBL] [Abstract][Full Text] [Related]
42. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
[TBL] [Abstract][Full Text] [Related]
43. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Inoue H
Protein Pept Lett; 2008; 15(8):850-3. PubMed ID: 18855759
[TBL] [Abstract][Full Text] [Related]
44. Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.
Zhang J; Liu X; Wang SQ; Liu GY; Xu WR; Cheng XC; Wang RL
J Biomol Struct Dyn; 2017 Sep; 35(12):2665-2680. PubMed ID: 27602589
[TBL] [Abstract][Full Text] [Related]
45. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
Mikami D; Kimura H; Kamiyama K; Torii K; Kasuno K; Takahashi N; Yoshida H; Iwano M
Hypertens Res; 2014 May; 37(5):422-31. PubMed ID: 24352213
[TBL] [Abstract][Full Text] [Related]
46. Telmisartan decreases plasma levels of asymmetrical dimethyl-L-arginine and improves lipid and glucose metabolism and vascular function.
Ono Y; Nakaya Y; Bando S; Soeki T; Ito S; Sata M
Int Heart J; 2009 Jan; 50(1):73-83. PubMed ID: 19246848
[TBL] [Abstract][Full Text] [Related]
47. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
48. Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
Nagashima A; Watanabe R; Ogawa M; Suzuki J; Masumura M; Hishikari K; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
J Cardiovasc Pharmacol; 2012 Aug; 60(2):158-64. PubMed ID: 22561360
[TBL] [Abstract][Full Text] [Related]
49. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation.
Yoshida T; Yamagishi S; Matsui T; Nakamura K; Ueno T; Takeuchi M; Sata M
J Int Med Res; 2008; 36(2):237-43. PubMed ID: 18380932
[TBL] [Abstract][Full Text] [Related]
50. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
Chaudagar KK; Mehta AA
Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
[TBL] [Abstract][Full Text] [Related]
51. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
Shiota A; Shimabukuro M; Fukuda D; Soeki T; Sato H; Uematsu E; Hirata Y; Kurobe H; Maeda N; Sakaue H; Masuzaki H; Shimomura I; Sata M
Cardiovasc Diabetol; 2012 Nov; 11():139. PubMed ID: 23137106
[TBL] [Abstract][Full Text] [Related]
52. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
53. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM
J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178
[TBL] [Abstract][Full Text] [Related]
54. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
Yao Y; Zou R; Liu X; Jiang J; Huang Q; He Y; Li M; Wang S; Zhou J; Ma D; Xu G
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):543-8. PubMed ID: 18846335
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
Benson SC; Iguchi R; Ho CI; Yamamoto K; Kurtz TW
J Hypertens; 2008 May; 26(5):973-80. PubMed ID: 18398340
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
57. Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.
Eslami H; Sharifi AM; Rahimi H; Rahati M
Neurosci Lett; 2014 Jan; 558():31-6. PubMed ID: 24211690
[TBL] [Abstract][Full Text] [Related]
58. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage.
Jung KH; Chu K; Lee ST; Kim SJ; Song EC; Kim EH; Park DK; Sinn DI; Kim JM; Kim M; Roh JK
J Pharmacol Exp Ther; 2007 Sep; 322(3):1051-8. PubMed ID: 17538008
[TBL] [Abstract][Full Text] [Related]
59. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
Xu L; Liu Y
Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
[TBL] [Abstract][Full Text] [Related]
60. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.
Wang J; Pang T; Hafko R; Benicky J; Sanchez-Lemus E; Saavedra JM
Neuropharmacology; 2014 Apr; 79():249-61. PubMed ID: 24316465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
